KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to -$1.2 billion.

  • Biogen's Cash from Investing Activities fell 652204.3% to -$1.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.4 billion, marking a year-over-year decrease of 7155.91%. This contributed to the annual value of -$1.4 billion for FY2025, which is 7155.91% down from last year.
  • Latest data reveals that Biogen reported Cash from Investing Activities of -$1.2 billion as of Q4 2025, which was down 652204.3% from -$35.1 million recorded in Q3 2025.
  • In the past 5 years, Biogen's Cash from Investing Activities ranged from a high of $1.7 billion in Q3 2022 and a low of -$1.7 billion during Q3 2023
  • Its 5-year average for Cash from Investing Activities is -$262.9 million, with a median of -$126.9 million in 2021.
  • In the last 5 years, Biogen's Cash from Investing Activities soared by 81583.9% in 2022 and then plummeted by 652204.3% in 2025.
  • Quarter analysis of 5 years shows Biogen's Cash from Investing Activities stood at -$112.7 million in 2021, then decreased by 25.2% to -$141.1 million in 2022, then plummeted by 362.3% to -$652.3 million in 2023, then skyrocketed by 97.15% to -$18.6 million in 2024, then crashed by 6522.04% to -$1.2 billion in 2025.
  • Its Cash from Investing Activities was -$1.2 billion in Q4 2025, compared to -$35.1 million in Q3 2025 and -$57.0 million in Q2 2025.